<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib1135">
 <element-citation publication-type="journal" id="sbref1135">
  <person-group person-group-type="author">
   <name>
    <surname>Pervaiz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zepp</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mahmood</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ali</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Berger</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Adwan</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer</article-title>
  <source>Cell. Oncol. Dordr. (Dordr)</source>
  <volume>42</volume>
  <year>2019</year>
  <fpage>93</fpage>
  <lpage>106</lpage>
  <pub-id pub-id-type="doi">10.1007/s13402-018-0415-3</pub-id>
 </element-citation>
</ref>
